Osaka, Japan

Junya Ueda



Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Junya Ueda: Innovator in Pharmaceutical Chemistry

Introduction

Junya Ueda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for treating various diseases. With a total of 2 patents, Ueda's work is recognized for its potential impact on medical treatments.

Latest Patents

Ueda's latest patents include innovative crystalline forms of complex compounds. These include 4, 4'-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl) butoxy] phenyl} ethynyl)-2-methyl-1H-indole-1,3-diyl] dibutanoic acid, and 4,4′-[2-methyl-7-({4-[4-(pentafluorophenyl) butoxy] phenyl} ethynyl)-1H-indole-1, 3-diyl] dibutanoic acid. His inventions focus on compounds that specifically bind to CCR5, which are useful for preventing and treating a range of diseases, including inflammatory, immunological, infectious, and allergic diseases.

Career Highlights

Junya Ueda is currently employed at Ono Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating pharmaceutical agents that address critical health issues. Ueda's innovative approach has garnered attention in the pharmaceutical industry.

Collaborations

Ueda has collaborated with notable colleagues, including Shinya Kusuda and Toshihiko Nishiyama. These partnerships have enhanced the scope and impact of his research, leading to significant advancements in pharmaceutical chemistry.

Conclusion

Junya Ueda's contributions to the field of pharmaceutical chemistry are noteworthy, with his innovative patents paving the way for new treatments. His work exemplifies the importance of research and collaboration in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…